257 related articles for article (PubMed ID: 24559822)
1. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
[TBL] [Abstract][Full Text] [Related]
3. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products.
Rawsthorne P; Clara I; Graff LA; Bernstein KI; Carr R; Walker JR; Ediger J; Rogala L; Miller N; Bernstein CN
Gut; 2012 Apr; 61(4):521-7. PubMed ID: 21836028
[TBL] [Abstract][Full Text] [Related]
4. Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile.
Fernández A; Simian D; Quera R; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Fluxá D
Complement Ther Med; 2018 Oct; 40():77-82. PubMed ID: 30219473
[TBL] [Abstract][Full Text] [Related]
5. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
[TBL] [Abstract][Full Text] [Related]
6. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
Am J Gastroenterol; 2003 Jul; 98(7):1563-8. PubMed ID: 12873578
[TBL] [Abstract][Full Text] [Related]
7. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
[TBL] [Abstract][Full Text] [Related]
8. Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.
Bertomoro P; Renna S; Cottone M; Riegler G; Bossa F; Giglio L; Pastorelli L; Papi C; Castiglione F; Angelucci E; Pica R; Di Paolo MC; D'Incà R
J Crohns Colitis; 2010 Sep; 4(3):291-300. PubMed ID: 21122518
[TBL] [Abstract][Full Text] [Related]
9. Health-related self-perceptions over time and provider-based Complementary and Alternative Medicine (CAM) use in people with inflammatory bowel disease or arthritis.
Sirois FM
Complement Ther Med; 2014 Aug; 22(4):701-9. PubMed ID: 25146075
[TBL] [Abstract][Full Text] [Related]
10. Complementary medicine use in children and young adults with inflammatory bowel disease.
Heuschkel R; Afzal N; Wuerth A; Zurakowski D; Leichtner A; Kemper K; Tolia V; Bousvaros A
Am J Gastroenterol; 2002 Feb; 97(2):382-8. PubMed ID: 11866277
[TBL] [Abstract][Full Text] [Related]
11. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use.
Langhorst J; Anthonisen IB; Steder-Neukamm U; Luedtke R; Spahn G; Michalsen A; Dobos GJ
Complement Ther Med; 2007 Mar; 15(1):30-7. PubMed ID: 17352969
[TBL] [Abstract][Full Text] [Related]
12. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.
Langhorst J; Anthonisen IB; Steder-Neukamm U; Lüdtke R; Spahn G; Michalsen A; Dobos GJ
Inflamm Bowel Dis; 2005 Mar; 11(3):287-95. PubMed ID: 15735435
[TBL] [Abstract][Full Text] [Related]
13. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway.
Opheim R; Bernklev T; Fagermoen MS; Cvancarova M; Moum B
Scand J Gastroenterol; 2012 Dec; 47(12):1436-47. PubMed ID: 23003678
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.
Gröchenig HP; Waldhör T; Haas T; Wenzl H; Steiner P; Koch R; Feichtenschlager T; Eckhardt G; Mayer A; Kirchgatterer A; Ludwiczek O; Platzer R; Papay P; Gartner J; Fuchssteiner H; Miehsler W; Peters PG; Reicht G; Kutschera M; Dejaco C; Vogelsang H; Novacek G;
Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1211-1219. PubMed ID: 31498280
[TBL] [Abstract][Full Text] [Related]
15. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).
Opheim R; Hoivik ML; Solberg IC; Moum B;
J Crohns Colitis; 2012 Apr; 6(3):345-53. PubMed ID: 22405172
[TBL] [Abstract][Full Text] [Related]
16. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
[TBL] [Abstract][Full Text] [Related]
17. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes.
Quattropani C; Ausfeld B; Straumann A; Heer P; Seibold F
Scand J Gastroenterol; 2003 Mar; 38(3):277-82. PubMed ID: 12737442
[TBL] [Abstract][Full Text] [Related]
18. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
[TBL] [Abstract][Full Text] [Related]
19. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease.
Day AS; Whitten KE; Bohane TD
J Paediatr Child Health; 2004 Dec; 40(12):681-4. PubMed ID: 15569284
[TBL] [Abstract][Full Text] [Related]
20. Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease.
Joos S; Rosemann T; Szecsenyi J; Hahn EG; Willich SN; Brinkhaus B
BMC Complement Altern Med; 2006 May; 6():19. PubMed ID: 16716218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
